* Data from AR101 for peanut allergy showed safety and
tolerability profile improved with continued treatment
The post BRIEF-Aimmune Therapeutics announces data supporting safety, tolerability profile of AR101 appeared first on NASDAQ.
Forex – financial instrument.Forex news
* Data from AR101 for peanut allergy showed safety and
tolerability profile improved with continued treatment
The post BRIEF-Aimmune Therapeutics announces data supporting safety, tolerability profile of AR101 appeared first on NASDAQ.